Merit Financial Group’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Sell |
91,316
-6,500
| -7% | -$14.1K | ﹤0.01% | 1567 |
|
|
2025
Q1 | $147K | Sell |
97,816
-700
| -0.7% | -$1.05K | ﹤0.01% | 1333 |
|
|
2024
Q4 | $496K | Buy |
98,516
+71,816
| +269% | +$361K | 0.01% | 730 |
|
|
2024
Q3 | $215K | Buy |
26,700
+5,000
| +23% | +$40.3K | ﹤0.01% | 767 |
|
|
2024
Q2 | $125K | Sell |
21,700
-500
| -2% | -$2.88K | ﹤0.01% | 884 |
|
|
2024
Q1 | $115K | Hold |
22,200
| – | – | ﹤0.01% | 838 |
|
|
2023
Q4 | $415K | Sell |
22,200
-19,000
| -46% | -$355K | 0.01% | 533 |
|
|
2023
Q3 | $391K | Sell |
41,200
-1,200
| -3% | -$11.4K | 0.01% | 511 |
|
|
2023
Q2 | $606K | Sell |
42,400
-500
| -1% | -$7.15K | 0.02% | 420 |
|
|
2023
Q1 | $661K | Sell |
42,900
-250
| -0.6% | -$3.85K | 0.02% | 346 |
|
|
2022
Q4 | $580K | Buy |
43,150
+23,150
| +116% | +$311K | 0.02% | 391 |
|
|
2022
Q3 | $274K | Buy |
+20,000
| New | +$274K | 0.01% | 457 |
|